Related Experiment Video
Updated: May 4, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Quality of life and supportive care in multiple myeloma
Melda Cömert1, Ajda Ersoy Güneş1, Fahri Sahin1
1Ege University School of Medicine, Department of Hematology, İzmir, Turkey.
Unlabelled:
Multiple myeloma is the second most common haematological malignancy. Novel therapies have led to improvement in survival. Current myeloma management is matching the progress made in improved survival through disease control while optimising quality of life with effective supportive care. Supportive treatment is an essential part of the therapeutic management of myeloma patients because it is directed towards improving the patient's quality of life and also can improve survival. The aim of this review is to highlight the relationship among life of quality, supportive care, and improvement in survival.
Conflict Of Interest:
None declared.
More Related Videos
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Related Concept Videos
Continuing Care
Treatment Resistant Cancers
Chronic Kidney Disease III: Interprofessional Care
Documentation in Long-Term and Home Healthcare Setting
Long-Term Care Facilities
Chronic Kidney Disease IV: Nursing Management
Nephrotic Syndrome III : Nursing Management